In vivo characterization of hyalonect, a novel biodegradable surgical mesh

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages

  Rhodes, Nicholas P ^a   Hunt, John A ^a   Longinotti, Cristina ^b   Pavesio, Alessandra ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Fidia Advanced Biopolymers   (Italy)

Author keywords

esterification; HYAFF; hyaluronan; membrane; mesh; periostium; reconstruction; regeneration

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE REGENERATION; CELL CULTURE; CONNECTIVE TISSUE; CONTROLLED STUDY; DOG; FASCIA; HISTOLOGY; HUMERUS FRACTURE; IMMUNE RESPONSE; IN VIVO STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PERIOSTEUM; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SURGICAL EQUIPMENT; TISSUE REGENERATION; VASCULARIZATION;

ABSORBABLE IMPLANTS; ANIMALS; BONE REGENERATION; FASCIA; FIBROSIS; HUMERUS; HYALURONIC ACID; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL MESH; TREATMENT OUTCOME;

EID: 79955629720     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.09.015     Document Type: Article

References (44)

1. 85Sr and gamma spectrometry. J Oral Implantol 1995;21:214.
2. Huller T, Nathan H. Does periosteum contribute to bone strength? Isr J Med Sci 1970;6:630.
3. Eyrebrook AL. The periosteum - its function reassessed. Clin Orthop Rel Res 1984;189:300.
4. Jacobsen FS. Periosteum: Its relation to pediatric fractures. J Pediatr Orthop B 1997;6:84.
5. Allen MR, Hock JM, Burr DB. Periosteum: Biology, regulation, and response to osteoporosis therapies. Bone 2004;35:1003.
6. Goldberg VM. Selection of bone grafts for revision total hip arthroplasty. Clin Orthop Rel Res 2000;381:68.
7. Lin KY, Bartlett SP, Yaremchuk MJ, et al. The effect of rigid fixation on the survival of onlay bone grafts: An experimental study. Plast Reconstr Surg 1990;86:449.
8. Lesley J, Hyman R. CD44 can be activated to function as an hyaluronic-acid receptor in normal murine T-cells. Eur J Immunol 1992;22:2719.
9. Noble PW, Lake FR, Henson PM, et al. Hyaluronate activation of CD44 induces insulin-like growth factor-I expression by a tumor-necrosis-factor-a dependent mechanism in murine macrophages. J Clin Invest 1993;91:2368.
10. Turley EA, Belch AJ, Poppema S, et al. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant lymphocytes-B. Blood 1993;81:446.
11. Weigel PH, Fuller GM, Le Boeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986;119:219.
12. West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial-cell proliferation and monolayer integrity. Exp Cell Res 1989;183:179.
13. West DC, Hampson IN, Arnold F, et al. Angiogenesis induced by degradation products of hyaluronic-acid. Science 1985;228:1324.
14. Toole BP. Hyaluronate and hyaluronidase in morphogenesis and differentiation. Am Zool 1973;13:1061.
15. Handley CJ, Lowther DA. Inhibition of proteoglycan biosynthesis by hyaluronic-acid in chondrocytes in cell-culture. Biochim Biophys Acta 1976;444:69.
16. Hay ED. Development of the vertebrate cornea. Int Rev Cytol 1979;63:263.
17. Boyce DE, Thomas A, Hart J, et al. Hyaluronic acid induces tumour necrosis factor-alpha production by human macrophages in vitro. Br J Plast Surg 1997;50:362.
18. Wisniewski HG, Vilcek J. TGS-6: An IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev 1997;8:143.
19. Campoccia D, Doherty P, Radice M, et al. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 1998;19:2101.
20. Benedetti L, Cortivo R, Berti T, et al. Biocompatibility and biodegradation of different hyaluronan derivatives (HYAFF) implanted in rats. Biomaterials 1993;14:1154.
21. Campoccia D, Hunt JA, Doherty PJ, et al. Quantitative assessment of the tissue response to films of hyaluronan derivatives. Biomaterials 1996;17:963.
22. Kujawa MJ, Carrino DA, Caplan AI. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev Biol 1986;114:519.
23. Zacchi V, Soranzo C, Cortivo R, et al. In vitro engineering of human skin-like tissue. J Biomed Mater Res 1998;40:187.
24. Tonello C, Zavan B, Cortivo R, et al. In vitro reconstruction of human dermal equivalent enriched with endothelial cells. Biomaterials 2003;24:1205.
25. Aigner J, Tegeler J, Hutzler P, et al. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res 1998;42:172.
26. Marsano A, Wendt D, Quinn TM, et al. Bi-zonal cartilaginous tissues engineered in a rotary cell culture system. Biorheology 2006;43:553.
27. Boyan BD, Lohmann CH, Romero J, et al. Bone and cartilage tissue engineering. Clin Plast Surg 1999;26:629.
28. Grigolo B, Lisignoli G, Piacentini A, et al. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAFF®-11): Molecular, immunohistochemical and ultrastructural analysis. Biomaterials 2002;23:1187.
29. Gao RZ, Dennis JE, Solchaga LA, et al. Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng 2002;8:827.
30. Solchaga LA, Temenoff JS, Gao JZ, et al. Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthr Cartilage 2005;13:297.
31. Lisignoli G, Fini M, Giavaresi G, et al. Osteogenesis of large segmental radium defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on nonwoven hyaluronic acid-based polymer scaffold. Biomaterials 2002;23:1043.
32. Rhodes NP, Srivastava JK, Smith RF, et al. Metabolic and histological analysis of mesenchymal stem cells grown in 3-D hyaluronan-based scaffolds. J Mater Sci Mater Med 2004;15:391.
33. Cristino S, Grassi F, Toneguzzi S, et al. Analysis of mesenchymal stem dimensional HYAFF 11 (R)-based cells grown on a prototype ligament scaffold. J Biomed Mater Res A 2005;73:275.
34. Revell PA, Damien E, Di Silvio L, et al. Tissue engineered intervertebral disc repair in the pig using injectable polymers. J Mater Sci Mater Med 2007;18:303.
35. Pastorino L, Soumetz FC, Ruggiero C. Nanofunctionalization for the treatment of peripheral nervous system injuries. IEE P Nanobiotech 2006;153:16.
36. Lepidi S, Abatangelo G, Vindigni V, et al. In vivo regeneration of small-diameter (2 mm) arteries using a polymer scaffold. FASEB J [Online] 2006;20:103. 10.1096/fj.05-4802fje.
37. Lepidi S, Grego F, Vindigni V, et al. Hyaluronan biodegradable scaffold for small-caliber artery grafting: Preliminary results in an animal model. Eur J Vasc Endovasc Surg 2006;32:411.
38. Zavan B, Brun P, Vindigni V, et al. Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: In vitro and in vivo studies. Biomaterials 2005;26:7038.
39. Tiedeman J, Garvin K, Kile T, et al. The role of a composite, demineralised bone matrix and bone marrow in the treatment of osseous defects. Orthopedics 1995;18:1153.
40. Sottosanti J. Calcium sulphate-aided bone regeneration: A case report. Periodont Clin Invest 1995;17:10.
41. Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes. Aust N Z J Surg 2001;71:354.
42. Urban RM, Turner TM, Hall DJ, et al. Healing of large defects treated with calcium sulfate pellets containing demineralised bone matrix particles. Orthopedics 2003;26:S581.
43. Urban RM, Turner TM, Hall DJ, et al. An injectable calcium sulfate-based bone graft putty using hydroxypropylmethylcellulose as the placticizer. Orthopedics 2004;27:S155.
44. Zhang X, Awad HA, O'Keefe RJ, et al. A perspective: Engineering periosteum for structural bone graft healing. Clin Orthop Relat Res 2008;466:1777.